Psychotic disorders affect around 20 million people worldwide, yet nearly all research on them comes from Europe, North America, and Australia. This programme expands that knowledge to India, Nigeria, and Trinidad—three very different settings where almost nothing was known about how psychoses develop or change over time. The problem is stark: without data from the Global South, clinicians lack evidence on how to treat psychotic disorders in most of the world. The team has already followed roughly 200 people with psychosis and 200 without in each site, revealing differences in prevalence, age of onset, risk factors, and short-term outcomes. But they do not know whether those differences persist over six years, why they exist, or how to help groups often excluded from research, such as homeless individuals with psychosis. If successful, this work will produce the first long-term, cross-continental picture of psychotic disorders outside wealthy countries. It will also create a web-based catalogue of similar studies worldwide, enabling researchers to compare data across many more settings. Finally, by working directly with people who have lived experience of psychosis, their carers, and local service providers, the team will develop tailored intervention packages for each site—interventions that could later be tested and implemented where they are most needed.
View original technical description
What is the programme about? Psychotic disorders are frequently distressing conditions in which people experience symptoms such as hallucinations (seeing or hearing things that are not there) and false thoughts or beliefs (delusions). These disorders usually begin at a young age (in the 20s) and often (but not always) lead to long term distress and suffering. Around 20 million people worldwide experience a psychotic disorder. However, what we know about these disorders is based on research done mainly in Europe, North America, and Australia. We do not know much about these disorders in other places, especially in the Global South. This is a problem because it means we do not know how best to treat those with a psychotic disorder in most places. Around 5 years ago, we started a programme of research to find out more about psychotic disorders in other places, specifically India, Nigeria, and Trinidad - chosen because they are very different from each other. In this, we identified and followed over time around 200 people with a psychotic disorder and 200 people without in each place. This work has already told us much we didn't know, which can be summarised as: there are differences across places in how common psychoses are, which groups are most affected, the typical age of onset, what factors increase risk, in physical health needs, and in short term outcomes (at 2 years). There is, however, much we still don't know: Do differences in outcome continue, over the medium and long term? What about groups typically not included in research, e.g., those who are homeless with a psychosis? Why are there such wide variations? And what about other places - do we see the same things? This current proposed programme builds on and extends the work already to answer these questions. What will we do? First, we will continue and expand our research India, Nigeria, and Trinidad. We will do this in two ways. (1) We will follow all individuals included in our previous work at 6 years after their first participation. We will collect information from them about how their symptoms and other aspects of their lives have changed over time (including those aspects of their lives they feel are most important). We will compare this information by place and by group, to see if there are similar and other differences to what we have observed before. (2) We will identify 60 more individuals with a psychotic disorder that have not been previously treated and 60 individuals without a psychotic disorder. This will allow us to look in more detail at some possible reasons why there are differences, e.g., perhaps because of differences in responses to stress, or differences in cognition, or differences in biological age (vs. actual age) - which may explain differences in physical health and mortality. Second, we will create a web-based catalogue of all studies of psychoses using similar approaches to ours around the world and, where possible, combine their data sets to enable researchers to conduct comparisons across a wider range of places. Third, we will work - in each setting in India, Nigeria, and Trinidad - with people with lived experience of psychosis, carers, and others such as service providers to develop new packages of interventions, tailored to the needs of each local setting. In future work, we will test and implement these interventions. What will the programme tell us? This programme will tell us more about how and why psychotic disorders differ between different countries and about how to intervene more effectively. Because we have so little information at the moment about these questions, our programme promises to have a big impact, both on our understanding of psychotic disorders and on how to intervene in more diverse settings.
Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.
Is something wrong? Let us know